Novartis, Roche near US drug price deal, Bloomberg News reports

Reuters12-18 02:20

UPDATE 2-Novartis, Roche near US drug price deal, Bloomberg News reports

Adds background in paragraphs 4-7

Dec 17 (Reuters) - The White House is set to announce drug pricing deals with pharmaceutical giants Novartis NOVN.S and Roche Holding ROG.S as soon as Friday, Bloomberg News reported on Wednesday, citing people familiar with the situation.

Other drugmakers could also be included in the announcement, and the details remain in flux, the report said.

The companies did not immediately respond to Reuters' requests for comment.

U.S. patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed countries, and President Donald Trump has been pressuring drugmakers to align prices with what is paid elsewhere.

Trump had sent letters to 17 leading drugmakers in July telling them to slash prices. Pfizer PFE.N and AstraZeneca AZN.L were the first two companies to reach deals with the Trump administration, agreeing to lower prescription drug prices in return for relief from tariffs.

Last month, Eli Lilly LLY.N and Novo Nordisk NOVOb.CO struck a deal to slash the prices of popular GLP-1 weight-loss drugs for the government's Medicare and Medicaid programs, as well as for cash payers.

Companies have also said they would sell drugs directly to patients in the U.S. and offered discounts following Trump's calls to bring down drug prices and cut out "middlemen" like pharmacies, insurers and pharmacy benefit managers.

(Reporting by Sriparna Roy in Bengaluru; Editing by Maju Samuel and Shilpi Majumdar)

((Sriparna.Roy@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592917960?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-18 02:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592917960","market":"us","top_or_hot":-1,"title":"Novartis, Roche near US drug price deal, Bloomberg News reports","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>UPDATE 2-Novartis, Roche near US drug price deal, Bloomberg News reports</title></head><body><p>Adds background in paragraphs 4-7</p><p>\n<span>Dec 17 (Reuters)</span><span> - </span>The White House is set to announce drug pricing deals with pharmaceutical giants Novartis <span>NOVN.S</span> and Roche Holding <span>ROG.S</span> as soon as Friday, Bloomberg News reported on Wednesday, citing people familiar with the situation.</p><p>Other drugmakers could also be included in the announcement, and the details remain in flux, the report said.</p><p>The companies did not immediately respond to Reuters' requests for comment.</p><p>U.S. patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed countries, and President Donald Trump has been pressuring drugmakers to align prices with what is paid elsewhere.</p><p>Trump had sent letters to 17 leading drugmakers in July telling them to slash prices. Pfizer <span>PFE.N</span> and AstraZeneca <span>AZN.L</span> were the first two companies to reach deals with the Trump administration, agreeing to lower prescription drug prices in return for relief from tariffs.</p><p>Last month, Eli Lilly <span>LLY.N</span> and <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> <span>NOVOb.CO</span> <span>struck a deal</span> to slash the prices of popular GLP-1 weight-loss drugs for the government's Medicare and Medicaid programs, as well as for cash payers.</p><p>Companies have also said they would sell drugs directly to patients in the U.S. and offered discounts following Trump's calls to bring down drug prices and cut out \"middlemen\" like pharmacies, insurers and pharmacy benefit managers.</p><p> (Reporting by Sriparna Roy in Bengaluru; Editing by Maju Samuel and Shilpi Majumdar)</p><p> ((Sriparna.Roy@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novartis, Roche near US drug price deal, Bloomberg News reports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovartis, Roche near US drug price deal, Bloomberg News reports\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-18 02:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>UPDATE 2-Novartis, Roche near US drug price deal, Bloomberg News reports</title></head><body><p>Adds background in paragraphs 4-7</p><p>\n<span>Dec 17 (Reuters)</span><span> - </span>The White House is set to announce drug pricing deals with pharmaceutical giants Novartis <span>NOVN.S</span> and Roche Holding <span>ROG.S</span> as soon as Friday, Bloomberg News reported on Wednesday, citing people familiar with the situation.</p><p>Other drugmakers could also be included in the announcement, and the details remain in flux, the report said.</p><p>The companies did not immediately respond to Reuters' requests for comment.</p><p>U.S. patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed countries, and President Donald Trump has been pressuring drugmakers to align prices with what is paid elsewhere.</p><p>Trump had sent letters to 17 leading drugmakers in July telling them to slash prices. Pfizer <span>PFE.N</span> and AstraZeneca <span>AZN.L</span> were the first two companies to reach deals with the Trump administration, agreeing to lower prescription drug prices in return for relief from tariffs.</p><p>Last month, Eli Lilly <span>LLY.N</span> and <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> <span>NOVOb.CO</span> <span>struck a deal</span> to slash the prices of popular GLP-1 weight-loss drugs for the government's Medicare and Medicaid programs, as well as for cash payers.</p><p>Companies have also said they would sell drugs directly to patients in the U.S. and offered discounts following Trump's calls to bring down drug prices and cut out \"middlemen\" like pharmacies, insurers and pharmacy benefit managers.</p><p> (Reporting by Sriparna Roy in Bengaluru; Editing by Maju Samuel and Shilpi Majumdar)</p><p> ((Sriparna.Roy@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999018865.SGD","symbol_name":"United Global Quality Growth Fd Cl Dist SGD-H","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL4N3XN1KN:1","article_id":"2592917960","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592917960","pubTimestamp":1765995637,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"UPDATE 2-Novartis, Roche near US drug price deal, Bloomberg News reportsAdds background in paragraphs 4-7","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SG9999018865.SGD":"United Global Quality Growth Fd Cl Dist SGD-H","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU1015430645.USD":"SCHRODER ISF UK EQUITY \"A\" (USDHDG) ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","BK4585":"ETF&股票定投概念","LU1127390331.HKD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"A\" (HKD) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","IE00BK4W5L77.USD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (USD) ACC","03165":"华夏欧优股对冲","LU0882574139.USD":"富达环球消费行业基金A ACC","LU2471134879.HKD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (HKD) INC","LU2552382132.HKD":"WELLINGTON US BRAND POWER \"A\" (HKD) ACC","LU1481600234.SGD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"ASC\" (SGDHDG) INC","LU1104425308.USD":"BNP PARIBAS EUROPE GROWTH \"C\" (USD) ACC","LU1051770623.HKD":"BGF EUROPEAN EQUITY INCOME \"A6\" (HKDHDG) INC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LLY":"礼来","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU2168564065.EUR":"AZ ALLOCATION - TREND \"AAZ\" (EUR) ACC","LU1170363599.USD":"ALLIANZ EUROPE EQUITY GROWTH SELECT \"A\" (USDHDG) INC","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","PFE":"辉瑞","LU0784384876.USD":"Blackrock Global Multi-Asset Income A6 USD","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU2168563687.JPY":"AZ ALLOCATION - TREND \"AAZ\" (JPYHDG) ACC","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","BK4592":"伊斯兰概念","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","LU2360106947.USD":"BGF NUTRITION \"A4\" (USD) INC","IE00BN29S564.USD":"JANUS HENDERSON BALANCED \"A3\" (USD) INC","LU0345777659.USD":"NINETY ONE GSF EUROPEAN EQUITY \"A\" (USD) INC","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","IE0005OL40V9.USD":"JANUS HENDERSON BALANCED \"A6M\" (USD) INC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU0964806797.USD":"UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY SUSTAINABLE (EUR) \"P\" (USHDG) ACC","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","LU0211326755.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU0345777147.USD":"NINETY ONE GSF EUROPEAN EQUITY \"A\" (USD) ACC","AZN.UK":"阿斯利康制药","LU0557290698.USD":"施罗德环球可持续增长基金","LU0757432116.USD":"THREADNEEDLE (LUX) PAN EUROPEAN ESG EQUITIES \"AE\" (USD) ACC","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","SG9999014914.USD":"UNITED GLOBAL QUALITY GROWTH (USDHDG) INC"},"translate_title":"据彭博新闻报道，诺华和罗氏即将达成美国药品价格协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03165":0.6,"PFE":0.9,"LLY":0.9,"AZN.UK":0.9},"content_text":"UPDATE 2-Novartis, Roche near US drug price deal, Bloomberg News reportsAdds background in paragraphs 4-7\nDec 17 (Reuters) - The White House is set to announce drug pricing deals with pharmaceutical giants Novartis NOVN.S and Roche Holding ROG.S as soon as Friday, Bloomberg News reported on Wednesday, citing people familiar with the situation.Other drugmakers could also be included in the announcement, and the details remain in flux, the report said.The companies did not immediately respond to Reuters' requests for comment.U.S. patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed countries, and President Donald Trump has been pressuring drugmakers to align prices with what is paid elsewhere.Trump had sent letters to 17 leading drugmakers in July telling them to slash prices. Pfizer PFE.N and AstraZeneca AZN.L were the first two companies to reach deals with the Trump administration, agreeing to lower prescription drug prices in return for relief from tariffs.Last month, Eli Lilly LLY.N and Novo Nordisk NOVOb.CO struck a deal to slash the prices of popular GLP-1 weight-loss drugs for the government's Medicare and Medicaid programs, as well as for cash payers.Companies have also said they would sell drugs directly to patients in the U.S. and offered discounts following Trump's calls to bring down drug prices and cut out \"middlemen\" like pharmacies, insurers and pharmacy benefit managers. (Reporting by Sriparna Roy in Bengaluru; Editing by Maju Samuel and Shilpi Majumdar) ((Sriparna.Roy@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592917960","isCrawlerRequest":true}